EFFECTS OF CARBON DIOXIDE, DICLOFENAC, AND THEIR COMBINATION ON THE COURSE OF MONOIODOACETIC ACID-INDUCED OSTEOARTHRITIS IN RATS

Authors:

Abstract:

Osteoarthritis is the most prevalent degenerative-inflammatory joint disease. Despite the widespread use of non-steroidal anti-inflammatory drugs and physiotherapeutic approaches, the majority of patients fail to achieve sustained clinical improvement, underscoring the need for novel therapeutic strategies. In this study, osteoarthritis was induced in 60 adult male outbred white rats by a single intra-articular injection of 0.05 ml of a 3 % monoiodoacetic acid solution into the right knee joint. Animals in the control group received physiological saline, whereas experimental groups were treated with: sodium diclofenac administered intraperitoneally 1 hour prior to induction and subsequently every 3 days; carbon dioxide administered subcutaneously in the periarticular region at a dose of 0.5 ml with the same frequency; or their combination. Histological examination of the joints was performed on days 14 and 28. Administration of CO₂ and diclofenac on day 14 of therapy reduced the severity of inflammatory-destructive changes in the articular cartilage and subchondral bone. The most pronounced anti-inflammatory and chondroprotective effect was observed in the group receiving combined CO₂ and diclofenac therapy. By day 28, necrotic-degenerative changes were attenuated, accompanied by partial restoration of the morphological structure of the articular cartilage and subchondral bone. Thus, combined administration of CO₂ and diclofenac demonstrated superior efficacy compared with monotherapy with either agent alone.

Keywords:

carbon dioxide diclofenac osteoarthritis morphological changes histological alterations knee joint rats

References:

1. Abramoff B, Caldera FE. Osteoarthritis: pathology, diagnosis, and treatment options. Med Clin North Am. 2020;104(2):293-311. doi:10.1016/j.mcna.2019.10.007.
2. Coaccioli S, Sarzi-Puttini P, Zis P, Rinonapoli G, Varrassi G. Osteoarthritis: new insight on its pathophysiology. J Clin Med. 2022;11(20):6013. doi:10.3390/jcm11206013.
3. Fischer AH, Jacobson KA, Rose J, Zeller R. Hematoxylin and eosin staining of tissue and cell sections. Cold Spring Harb Protoc. 2008;2008(6):pdb.prot4986. doi:10.1101/pdb.prot4986.
4. Galganska H, Jarmuszkiewicz W, Galganski L. Carbon dioxide inhibits COVID-19-type proinflammatory responses through extracellular signal-regulated kinases 1 and 2, novel carbon dioxide sensors. Cell Mol Life Sci. 2021;78(24):8229-42. doi:10.1007/s00018-021-04005-3.
5. Henrotin Y. Osteoarthritis in year 2021: biochemical markers. Osteoarthritis Cartilage. 2022;30(2):237-48. doi:10.1016/j.joca.2021.11.001.
6. Kloppenburg M, Berenbaum F. Osteoarthritis year in review 2019: epidemiology and therapy. Osteoarthritis Cartilage. 2020;28(3):242-8. doi:10.1016/j.joca.2020.01.002.
7. McCoy AM. Animal models of osteoarthritis: comparisons and key considerations. Vet Pathol. 2015;52(5):803-18. doi:10.1177/0300985815588611.
8. Ohzono H, Hu Y, Nagira K, Kanaya H, Okubo N, Olmer M, et al. Targeting FoxO transcription factors with HDAC inhibitors for the treatment of osteoarthritis. Ann Rheum Dis. 2023;82(2):262-71. doi:10.1136/ard-2021-221269.
9. Pishgahi A, Zamani M, Mehdizadeh A, Roshangar L, Afkham-Daghdaghan M, et al. The therapeutic effects of autologous conditioned serum on knee osteoarthritis: an animal model. BMC Res Notes. 2022;15(1):277. doi:10.1186/s13104-022-06166-1.
10. Riewruja K, Makarczyk M, Alexander PG, Gao Q, Goodman SB, Bunnell BA, et al. Experimental models to study osteoarthritis pain and develop therapeutics. Osteoarthritis Cartilage Open. 2022;4(4):100306. doi:10.1016/j.ocarto.2022.100306.
11. Shtroblia V, Lutsenko R. Study of the potential analgesic properties of carbon dioxide for the treatment of pain syndrome in case of osteoarthritis. Orthop Traumatol Prosthetics. 2024;3:70-5. doi:10.15674/0030-59872024370-75.
12. Tang SE, Wu SY, Chu SJ, Tzeng YS, Peng CK, Lan CC, et al. Pre-treatment with ten-minute carbon dioxide inhalation prevents lipopolysaccharide-induced lung injury in mice via down-regulation of Toll-like receptor 4 expression. Int J Mol Sci. 2019;20(24):6293. doi:10.3390/ijms20246293.
13. Wang Y, Zeng T, Tang D, Cui H, Wan Y, Tang H. Integrated multi-omics analyses reveal lipid metabolic signature in osteoarthritis. J Mol Biol. 2025;437(6):168888. doi:10.1016/j.jmb.2024.168888.
14. Xu J, Wang C, Jin Y, Meng Q, Liu Q, Fan Z, et al. Modulation of macrophage polarization in osteoarthritis by platelet-rich plasma in vitro and in vivo. Front Immunol. 2024;15:1357793. doi:10.3389/fimmu.2024.1357793.
15. Zhdan VN, Tkachenko MV, Kitura YeM, Babanina MYu, Kyrian OA. Osteoarthritis and metabolic syndrome: unity of pathogenetic mechanisms. World Med Biol. 2021;4(78):56-60.

Publication:

«World of Medicine and Biology» Vol. 21 No. 93 (2025) , с. 204-209
УДК 616.728.3-002.77-092.9:615.2

DOI:

https://doi.org/10.26724/2079-8334-2025-3-93-204-209